22,414-Patient DarioHealth Study Finds 12 Monthly Checks Drive Glycemic Improvement
DarioHealth’s machine learning study of 22,414 type 2 diabetes patients found users averaging at least 12 monthly glucose measurements achieved significant early reductions in blood glucose levels. Researchers identified that consistent engagement metrics, including frequent monitoring and lifestyle activity tags, predict durable glycemic improvements across diverse demographics.
1. Study Overview
The observational analysis evaluated real-world data from 22,414 adults with type 2 diabetes and high-risk baseline blood glucose levels. Advanced machine learning models and longitudinal mixed-effects analyses identified personalized glycemic trajectories moderated by demographic, clinical and engagement factors.
2. Key Findings
Frequent glucose monitoring—identified at a threshold of 12 measurements per month—and lifestyle activity tagging were linked to substantial early reductions and sustained stabilization in blood glucose. No meaningful BMI differences were observed across ethnicities, indicating consistent benefits across diverse user groups.
3. Business Implications
These results reinforce engagement as a clinical signal and strengthen DarioHealth’s value proposition to employers, health plans and risk-bearing providers by translating scalable real-world data into measurable ROI and personalized diabetes management solutions.